These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Efficacy of ribavirin aerosol treatment for respiratory syncytial virus bronchiolitis in infants.
    Author: Caramia G, Palazzini E.
    Journal: J Int Med Res; 1987; 15(4):227-33. PubMed ID: 3653500.
    Abstract:
    The therapeutic efficacy of ribavirin, an anti-viral agent with a broad spectrum of activity, was studied in 14 infants with bronchiolitis which, in seven cases, was caused by a respiratory syncytial virus infection. The drug was administered for 5-6 days using an aerosol in periods of either 4 or 6 h with an interval of either 4 or 2 h between administrations. The body temperature of patients with fever returned to normal by day 3 of therapy. A significant decrease in the respiratory rate occurred by day 2 when there was also a marked improvement in the subjective and objective symptomatology. The most significant clinical improvements occurred in infants presenting a respiratory syncytial virus antigen in nasal wash specimens. This suggests therapeutic selectivity by ribavirin for (or a more pronounced sensibility of) this virus.
    [Abstract] [Full Text] [Related] [New Search]